Boosting Boron Neutron Capture Therapy through Ferroptosis Activation with a Biomimetic Nanoenhancer
Biomaterials Research · 01.01.2026 · 30
DOI: 10.34133/bmr.0343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 03.04.2026. Verfasst von Jiayi Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Yanbian University, Yanji133002, Jilin, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Beijing Nova Program.
Abstract (Originalsprache)
Boron neutron capture therapy (BNCT) is an emerging tumor radiotherapeutic modality, but its efficacy is limited by incomplete understanding of tumor cell death mechanisms. Here, we demonstrate that BNCT fails to sufficiently induce ferroptosis—a form of programmed cell death with important implications for both tumor elimination and immune activation—which constrains its therapeutic potential. Using proteomic profiling across multiple tumor cell lines, we found that although BN-triggered mitochondrial dysfunction activated several death-related pathways, robust ferroptosis was not achieved. To address this, we developed a biomimetic nanoagent, m(E@BN), composed of erastin-loaded boron nitride nanosheets coated with tumor cell membranes for targeted delivery. This system significantly enhanced BNCT-induced ferroptosis in vitro and in vivo, synergistically promoting lipid peroxidation and iron metabolism dysregulation without aggravating DNA injury. Furthermore, m(E@BN)-augmented BNCT stimulated potent antitumor immunity, evidenced by increased T cell infiltration and establishment of immune memory. Our study not only elucidates a mechanistic limitation of BNCT but also offers an effective nanomedicine-based strategy to amplify its efficacy through ferroptosis activation, providing a broadly applicable paradigm for improving radiotherapeutic outcomes.
Autor:innen und Institutionen
- Medical College of Yanbian University, Yanji133002, Jilin, China.
- CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Beijing Nova Program
- Guangdong Basic and Applied Basic Research Foundation
- State Key Laboratory of Advanced Drug Delivery and Release Systems
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, J., Lv, L., Li, H., Pan, X., Zhang, J., Li, J., Yan, R., Wan, J., Liang, H., Peng, B., Yang, M., Chang, Y., Li, J., Yuan, H., Shen, M., Xing, G., & Chen, K. (2026). Boosting Boron Neutron Capture Therapy through Ferroptosis Activation with a Biomimetic Nanoenhancer. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0343
Vancouver
Wang J, Lv L, Li H, Pan X, Zhang J, Li J, et al. Boosting Boron Neutron Capture Therapy through Ferroptosis Activation with a Biomimetic Nanoenhancer. Biomaterials Research. 2026;30. doi:10.34133/bmr.0343
BibTeX
@article{Wang2026,
author = {Wang, Jiayi and Lv, Linwen and Li, Hao and Pan, Xin and Zhang, Junhui and Li, Jiaxuan and Yan, Ruyu and Wan, Jiaxin and Liang, Haojun and Peng, Bingbing and Yang, Mingxin and Chang, Yanan and Li, Juan and Yuan, Hui and Shen, Minghua and Xing, Gengmei and Chen, Kui},
title = {Boosting Boron Neutron Capture Therapy through Ferroptosis Activation with a Biomimetic Nanoenhancer},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0343}
}
EUVIMED